Researcher
Joy LODEWIJCKX
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Cancer therapy, Oncology not elsewhere classified
Affiliations
- Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Feb 2024 → Today - Cardio & organ systems (Department)
Member
From1 Feb 2024 → Today - Cardio & organ systems (Research group)
Member
From1 Feb 2024 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Feb 2024 → Today - Cardio & organ systems (Department)
Member
From1 Jan 2020 → 31 Dec 2023 - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → 31 Dec 2023 - Cardio & organ systems (Research group)
Member
From1 Jan 2020 → 31 Dec 2023 - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jul 2018 → 31 Dec 2023 - Immunology - Biochemistry (Research group)
Member
From16 Jul 2018 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From16 Jul 2018 → 31 Dec 2019
Projects
1 - 2 of 2
- Photobiomodulation therapy for the management of cancer therapy-related side effectsFrom1 Sep 2021 → TodayFunding: Nonprofit institution or equivalents
- Photobiomodulation therapy for the prevention and management of chemotherapy-induced side effectsFrom1 Aug 2019 → 31 Dec 2023Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 25
- A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial(2023)
Authors: Jolien ROBIJNS, Leen Van Bever, Sanne Hermans, Marithe CLAES, Joy LODEWIJCKX, Melissa Lenaerts, Laura Tuts, Eline Vandaele, Evelien Vinken, Leen Noé, et al.
- The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial)(2023)
Authors: Joy LODEWIJCKX, Jolien ROBIJNS, Marithe CLAES, Maud Pierson, Melissa Lenaerts, Jeroen MEBIS
- Photobiomodulation in the management of chemotherapy-induced peripheral neuropathy: a randomized, controlled trial(2023)
Authors: Marithe CLAES, Joy LODEWIJCKX, S. Hermans, P. Peeters, Jeroen MEBIS, Jolien ROBIJNS
Pages: 97 - 119 - Evaluation of a novel skin care product for the management of chemotherapy– related dermatologic toxicities: A quasi-experimental study(2023)
Authors: Jolien ROBIJNS, Joy LODEWIJCKX, Marithe CLAES, Laura Tuts, Melissa Lenaerts, Tim Wessels, Annelies Requilé, Daisy Luyten, Jolanda Verheezen, Eric Joosens, et al.
- Photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy (NEUROLASER trial)(2022)
Authors: Joy LODEWIJCKX, Jolien ROBIJNS, Marithe CLAES, S. Hermans, Jeroen MEBIS
Pages: 327 - Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole‐breast irradiation (LABRA trial)(2022)
Authors: Jolien ROBIJNS, Joy LODEWIJCKX, Leen Van Bever, Sofie Puts, An Timmermans, Leen Noe, Sofie Vanmechelen, Mieke Govers, Evelyn Van de Werf, Annelies MAES, et al.
Pages: 374 - 383 - Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial(2022)
Authors: Joy LODEWIJCKX, Jolien ROBIJNS, Marithe CLAES, Jeroen MEBIS
Pages: S225 - Photobiomodulation therapy for the prevention and management of chemotherapy-induced peripheral neuropathy and chemotherapy-induced alopecia(2022)
Authors: Joy LODEWIJCKX, Jeroen MEBIS
Number of pages: 204 - Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMIS- HEAD trial)" by He et al(2022)
Authors: Jolien ROBIJNS, Joy LODEWIJCKX, Stefan Claes, Leen Van Bever, Luc Pannekoeke, Sandrine Censabella, Lore Busse, Dora COLSON, Iris Kaminski, Victoria Broux, et al.
Pages: 143 - 144 - PHOTOBIOMODULATION THERAPY CAN PREVENT THE DEVELOPMENT OF SEVERE ACUTE RADIODERMATITIS IN HEAD AND NECK CANCER PATIENTS: A MULTICENTRIC, RANDOMIZED CONTROLLED TRIAL(2021)
Authors: Jolien ROBIJNS, Joy LODEWIJCKX, Jeroen MEBIS
Pages: S19